Dr. Nasser Al-Hajj is a Lecturer in the Department of Science at South East Technological University (SETU), Ireland. His primary research focus lies in pulmonary drug delivery, particularly for cystic fibrosis treatments. He actively engages in collaborations and is accepting PhD students for research projects. Education: Master of Science in Pharmaceutics, Universiti Teknologi MARA (2017) Bachelor of Pharmacy and Pharmacological Chemistry, Tishreen University (2006) Dr. Al-Hajj's research interests involve: Spray drying techniques for inhalable drug formulations Dry powder inhalation therapies targeting Pseudomonas aeruginosa biofilms Nanoparticle and microparticle engineering for targeted pulmonary delivery Combination therapies with ciprofloxacin and quercetin for cystic fibrosis His recent publications (2022-2023) demonstrate expertise in: Treatment of cystic fibrosis lung infections Optimization of inhalable antibiotics Quality-by-design approaches in drug formulation Development of nano-in-microparticle systems Current research collaborations span pharmaceutical sciences, biomedical engineering, and clinical respiratory medicine, emphasizing translational applications.